The Globe and Mail

Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and ...

NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the publication of data from a post hoc pooled analysis of the Phase 3 ULTIMATE I and II studies ...